Checked by Scott E. Denmark and William R. Collins.
1. Procedure
2. Notes
1.
3-Chloropropionic acid was purchased from Acros Organics and used as received.
2.
Triphenylphosphine was purchased from Acros Organics and used as received.
3.
Xylenes were purchased from Mallinckrodt Inc. and used as received.
4.
Acetonitrile was purchased from J. T. Baker and used as received.
5.
Scraping the precipitated material was crucial to induce solidification of the product, which initially separated out of the xylene solution as a taffy-like material.
6.
Washing should be continued with diethyl ether until the wash solvent no longer appears white after filtration.
7.
The product displayed the following properties: mp 201–204 °C (sealed tube); IR (neat): cm-1 2900, 1742, 1421, 1586, 1489, 1439, 1421, 1388, 1352, 1220, 1165, 1116, 1037, 996, 950, 910, 859, 816, 752, 698, 613;
1H NMR
pdf (500 MHz, CDCl
3) δ: 3.09–3.15 (m, 2 H), 3.69–3.75 (m, 2 H), 7.69–7.84 (m, 15 H);
13C NMR
pdf (125 MHz, CDCl
3) δ: 19.1, 28.1, 117.2, 130.4, 133.4, 171.3, 135.2; LRMS EI (relative intensity)
m/z: 369 ([M]
+, 6), 317 (5), 262 (100), 183 (25), 152 (4); Anal. Calcd for C
21H
20ClO
2P: C, 68.02; H, 5.44. Found: C, 68.03; H, 5.48. The spectroscopic data were consistent with previously reported literature values.
2a,b The procedure described herein is a modified version of a literature procedure.
2b
8.
Magnesium turnings were purchased from Fisher Scientific and used as received.
9.
Diethyl ether was purchased from EMD Chemicals Inc., dried over 4Å molecular sieves overnight and further dried by pressure filtration through activated alumina.
10.
Iodomethane (99%) was purchased from Aldrich Chemical Company, Inc. and used as received. It is classified as a carcinogen and should be handled with care
11.
α-Tetralone was purchased from Aldrich Chemical Company, Inc. (98%) and used as received.
12.
Silica gel was purchased from Silicycle (40–63 μm particle size, 60 Å pore diameter) and loaded as a slurry onto a 30-mm diameter column. Fractions were collected (19 mL) and elution monitored by TLC (silica gel, R
f 0.51, pentane).
13.
The submitters occasionally found that the product was contaminated with the isomeric 1-methylene-1,2,3,4-tetrahydronaphthalene in a 25:1 ratio on some of the trials. This impurity was inseparable by chromatography but was converted quantitatively to the desired product by refluxing the mixture in toluene with 1 mol % toluenesulfonic acid monohydrate for 1 h.
14.
The product displayed the following properties: R
f 0.51 (pentanes); IR (neat): cm-1 3097, 3060, 2933, 2883, 2830, 2856, 1487, 1450, 1438, 1427, 1378, 1239, 1069, 1039, 1020, 936, 886, 868, 812, 791, 756, 731, 704, 633;
1H NMR
pdf (500 MHz, CDCl
3) δ: 2.09 (s, 3 H), 2.27–2.31 (m, 2 H), 2.79 (t,
J=8.5 Hz, 2 H), 5.88 (m, 1 H), 7.17–7.22 (m, 2 H), 7.22–7.29 (m, 2 H);
13C NMR
pdf (125 MHz, CDCl
3) δ: 23.4, 28.6, 122.9, 125.6, 126.5, 126.9, 127.6, 132.4, 136.1, 136.5; LRMS EI (relative intensity)
m/z: 144 ([M]
+, 100), 129 (47), 115 (10), 102 (4), 89 (5), 77 (3), 63 (5); Anal. Calcd for C
11H
12: C, 91.61; H, 8.39. Found: C, 91.57; H, 8.22. The spectroscopic data were consistent with previously reported literature values.
3 The procedure described herein is a modified version of a literature procedure.
3
15.
Benzaldehyde (redistilled, 99.5+%) was purchased from Aldrich Chemical Company, Inc. and used as received.
16.
THF was purchased from J. T. Baker Chemical Co., dried over 4 Å molecular sieves overnight and further dried by pressure filtration through activated alumina.
17.
Potassium tert-butoxide (98+%) was purchased from Acros Organics and used as received. The solution in THF was cooled externally to 0 °C in an ice-water bath before and during addition.
18.
Dimethyl sulfate was purchased from Acros Organics and used as received. It is classified as a carcinogen and should be handled with care.
19.
p-Acetamidobenzenesulfonyl azide (p-ABSA) is commercially available (Aldrich Chemical Company, Inc.), but was prepared by the submitters using the published procedure, See
Org. Synth., Coll. Vol. IX 1998, 422. Although the compound has not exhibited shock sensitivity,
4 all azide compounds should be handled with care.
20.
DBU was purchased from Acros Organics and used as received.
21.
The reaction mixture was concentrated on a rotary evaporator in a fume hood because of the excess dimethyl sulfate that was collected in the receiver.
22.
Anhydrous
MgSO4 was purchased from Fisher Scientific Company.
23.
Silica gel was purchased from Silicycle (40–63 μm particle size, 60 Å pore diameter) and loaded as a slurry onto a 60-mm diameter column.
24.
The product displayed the following properties: R
f 0.35 (9:1 pentane/ether); IR (neat): cm-1 2960, 2168, 2088(C=N
2), 1706, 1626, 1492, 1449, 1438, 1405, 1364, 1318, 1286, 1243, 1194, 1113, 1010, 950, 752, 734, 692;
1H NMR
pdf (500 MHz, CDCl
3) δ: 3.86 (s, 3 H), 6.20 (d,
J =16.0 Hz, 1 H), 6.49 (d,
J= 16.0 Hz, 1 H), 7.20 (t,
J = 7.5 Hz, 1 H), 7.30–7.37 (m, 4 H);
13C NMR
pdf (125 MHz, CDCl
3) δ: 52.05, 111.0, 122.8, 125.6, 126.8, 128.4, 136.5, 165.0; LRMS EI (relative intensity)
m/z: 202.1 ([M]
+, 38), 170.0 (10), 159 (4), 142 (12), 129 (16)); Anal. Calcd for C
11H
10N
2O
2 C, 65.34; H, 4.98; N, 13.85, Found: C, 65.40; H, 4.94; N, 13.70 The procedure described herein is a modified version of a literature procedure.
5 The product should be stored at 0 °C and immediately purified before use if stored for more than ~2 days as it will slowly undergo an electrocyclization reaction to form a pyrazole. The pyrazole is observed as a white crystalline solid.
All diazo compounds should be handled carefully, although in this case, the only thermal decomposition pathway exhibited by this compound in the absence of catalyst is electrocyclization to the pyrazole. The compound should not be stored in solution as this accelerates the decomposition reaction.
25.
Rh
2(
S-DOSP)
4 is commercially available from Strem Chemicals, Inc. and Aldrich Chemical Company, Inc. and is air stable. Alternatively, it can be readily made by the published procedure.
6
26.
2,2-Dimethylbutane (DMB) was purchased from Lancaster Synthesis and distilled from sodium under argon prior to use.
27.
(
E)-Methyl 2-diazo-4-phenyl-3-butenoate
1 was freshly purified when used. The checkers found that 500 μL of diethyl ether was needed to wet the solid before it was diluted with DMB. If the diethyl ether was not used, the starting material was not completely soluble in the DMB.
28.
The checkers found that carrying out the syringe pump addition with a 50-mL syringe led to clogging from formation of the insoluble pyrazole. The best results were obtained by carrying out the addition in six portions with a 10-mL syringe with a 16-gauge needle (40 min per addition for the total of a 4-h addition period).
29.
The product was obtained in 87–92% yield when purified by silica gel column chromatography (See Table 2), but contained a slight greenish tinge. The product displayed the following properties: mp 77–79 °C (sealed tube), R
f 0.35 (10:1 pentane/ether); IR (KBr): cm-1 2946, 1956, 1886, 1735, 1638, 1487, 1450, 1427, 1380, 1331, 1298, 1264, 1215, 1151, 1098, 1024, 993, 972, 944, 902, 842, 807, 761, 723, 659;
1H NMR
pdf (500 MHz, CDCl
3) δ: 2.07 (s, 3 H), 2.72 (m, 1 H), 2.84–2.88 (m, 2 H), 3.11 (t,
J=9.5 Hz, 1 H), 3.69 (s, 3 H), 5.73 (d,
J=3.5 Hz, 1 H), 6.14 (dd,
J=16.0, 9.5 Hz, 1 H), 6.42 (d,
J=16.0 Hz, 1 H), 7.08 (d,
J= 7.0 Hz, 1 H), 7.15 (td,
J= 7.0, 2.0 Hz, 1 H), 7.23–7.24 (m, 4 H), 7.30–7.36 (m, 4 H);
13C NMR
pdf (125 MHz, CDCl
3) δ: 19.4 (CH
3), 31.7, 36.1, 51.9, 53.2, 123.0, 126.0, 126.2, 126.4, 126.6, 127.2, 127.7, 127.8, 128.5, 134.4, 135.3, 136.6, 173.6; LRMS ESI (relative intensity)
m/z: 319.2 ([M+H]
+,7), 341.1 ([M+Na]
+, 0.4), 287 (3), 259.1 (3), 176 (100), 143 (94); HPLC analysis: >99.8:0.2 (unable to accurately integrate minor enantiomer) (Chiralcel OD-H, 2%
i-PrOH in hexane, 0.8 mL/min, λ = 254 nm, tR = 7.25 min , major; tR = 7.99 min, minor); Anal. Calcd for C
22H
22O
2: C, 82.99; H, 6.96. Found: C, 82.62; H, 6.94. [α]D = −21.4 (c = 1.0, ethanol). The procedure described herein is a modified version of a literature procedure.
7
The procedures in this article are intended for use only by persons with prior training in experimental organic chemistry. All hazardous materials should be handled using the standard procedures for work with chemicals described in references such as "Prudent Practices in the Laboratory" (The National Academies Press, Washington, D.C., 2011 www.nap.edu). All chemical waste should be disposed of in accordance with local regulations. For general guidelines for the management of chemical waste, see Chapter 8 of Prudent Practices.
These procedures must be conducted at one's own risk. Organic Syntheses, Inc., its Editors, and its Board of Directors do not warrant or guarantee the safety of individuals using these procedures and hereby disclaim any liability for any injuries or damages claimed to have resulted from or related in any way to the procedures herein.
3. Discussion
The combined C-H activation/Cope rearrangement reaction has proven to be a very favorable transformation and catalyst loadings as low as 0.01 mol% can be used with no significant drop in yield or stereoselectivity (Table 2).
Appendix
Chemical Abstracts Nomenclature (Collective Index Number);
(Registry Number)
3-Chloropropionic acid:
Propanoic acid, 3-chloro-; (107-94-8)
Triphenylphosphine; (603-35-0)
2-Carboxyethyltriphenylphosphonium chloride; (36626-29-6)
Iodomethane; (74-88-4)
Magnesium (7439-95-4)
a-Tetralone:
1(2H)-Naphthalenone, 3,4-dihydro-; (529-34-0)
1-Methyl-3,4-dihydronaphthalene:
Naphthalene, 1,2-dihydro-4-methyl-; (4373-13-1)
(E)-Methyl 2-diazo-4-phenylbut-3-enoate: (119987-21-2)
Benzaldehyde; (100-52-7)
Potassium tert-butoxide:
2-Propanol, 2-methyl-, potassium salt (1:1); (865-47-4)
Dimethyl sulfate:
Sulfuric acid, dimethyl ester; (77-78-1)
p-Acetamidobenzenesulfonyl azide:
Benzenesulfonyl azide, 4-(acetylamino)-; (2158-14-7)
DBU:
Pyrimido[1,2-a]azepine, 2,3,4,6,7,8,9,10-octahydro-; (6674-22-2)
(S,E)-Methyl 2-((R)-4-methyl-1,2-dihydronaphthalen-2-yl)-4-phenylbut-3-enoate:
2-Naphthaleneacetic acid, 1,2-dihydro-4-methyl-α-[(1E)-2-phenylethenyl]-, methyl ester, (αS,2R)-; (76531-50-5)
Rh2(S-DOSP)4; (179162-34-6)
Copyright © 1921-, Organic Syntheses, Inc. All Rights Reserved